Literature DB >> 29314221

Diagnosis of cognitive decline and dementia in rural areas - A scoping review.

Janina Barth1,2, Franziska Nickel1,2, Peter L Kolominsky-Rabas1,2.   

Abstract

OBJECTIVES: Due to the demographic change, the global prevalence of dementia will continually rise. Barriers to diagnosis and care are still high. But timely diagnosis is associated with valuable benefits and can promote timely and optimal management. Receiving an early diagnosis is especially in rural areas a problem due to the limited access to assessments. Therefore, the aim of our scoping review is to investigate different interventions targeted at rural living elderly to screen and diagnose cognitive decline and dementia.
METHODS: A scoping review was conducted in line with the framework of Arksey and O'Malley. The following databases were systematically searched: PubMed, PsycINFO, Cochrane Library, and ScienceDirect. The interventions were categorized in four main categories (interventions for general practitioners/institutions; online/mobile offers; telehealth applications; telephone-based screenings).
RESULTS: Thirty studies were included. The four categories show different scopes of application. Telehealth applications show that it is feasible and valid to diagnose dementia via videoconference. Assessments described in three other categories show that remotely used tools are appropriate to screen for mild cognitive impairment or cognitive decline, but are not valid to establish a dementia diagnosis.
CONCLUSIONS: Telehealth applications can appropriately be used to diagnose dementia. However, most of the studies included only small sample sizes and did not test the applications explicitly in rural or remote populations. Therefore, studies taking these limitations into account are needed. On top, only two RCTs are included in this review indicating that more high quality studies in this field are needed.
Copyright © 2018 John Wiley & Sons, Ltd.

Entities:  

Keywords:  cognitive decline; dementia; diagnosis; rural areas; screening

Mesh:

Year:  2018        PMID: 29314221     DOI: 10.1002/gps.4841

Source DB:  PubMed          Journal:  Int J Geriatr Psychiatry        ISSN: 0885-6230            Impact factor:   3.485


  7 in total

Review 1.  Diagnostic test accuracy of remote, multidomain cognitive assessment (telephone and video call) for dementia.

Authors:  Lucy C Beishon; Emma Elliott; Tuuli M Hietamies; Riona Mc Ardle; Aoife O'Mahony; Amy R Elliott; Terry J Quinn
Journal:  Cochrane Database Syst Rev       Date:  2022-04-08

2.  Associated factors for cognitive impairment in the rural highly elderly.

Authors:  Hyeyun Kim; Sujin Lee; Bon D Ku; Su Geun Ham; Woong-Sub Park
Journal:  Brain Behav       Date:  2019-04-01       Impact factor: 2.708

3.  Digital Dementia Registry Bavaria-digiDEM Bayern: study protocol for a multicentre, prospective, longitudinal register study.

Authors:  Nikolas Dietzel; Lara Kürten; Linda Karrer; Michael Reichold; Laura Köhler; Andreas Nagel; Christina Chmelirsch; Kathrin Seebahn; Markus Hladik; Sebastian Meuer; Anna Kirchner; Kristina Holm; Marina Selau; Marco Wendel; Jörg Trinkwalter; Hans-Ulrich Prokosch; Elmar Graessel; Peter L Kolominsky-Rabas
Journal:  BMJ Open       Date:  2021-02-08       Impact factor: 2.692

4.  Acceptability of collecting speech samples from the elderly via the telephone.

Authors:  Catherine Diaz-Asper; Chelsea Chandler; R Scott Turner; Brigid Reynolds; Brita Elvevåg
Journal:  Digit Health       Date:  2021-04-17

Review 5.  Virtual care for patients with Alzheimer disease and related dementias during the COVID-19 era and beyond.

Authors:  Paula J Gosse; Charles D Kassardjian; Mario Masellis; Sara B Mitchell
Journal:  CMAJ       Date:  2021-03-15       Impact factor: 8.262

Review 6.  Mild Cognitive Impairment in Rural Areas: Research Advances and Implications for Clinical Practice and Healthcare Policy.

Authors:  Vaios Peritogiannis; Aglaia Roganaki; Eleftheria Siarava; Maria Samakouri
Journal:  Healthcare (Basel)       Date:  2022-07-19

Review 7. 

Authors:  Paula J Gosse; Charles D Kassardjian; Mario Masellis; Sara B Mitchell
Journal:  CMAJ       Date:  2021-06-07       Impact factor: 8.262

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.